Ardelyx (NASDAQ:ARDX) reported quarterly earnings results on February 19, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $0.00, missing the consensus estimate of $0.01 by $0.01 per share. Revenue came in at $125.2M, beating the estimate of $117.9M.
Ardelyx's stock moved following the earnings release. The stock currently trades at $5.95 with a market capitalization of $1.4B.